Inside Clinuvel

The last five years have brought much change in the global pharmaceutical industry. As one of thousands of firms working in the space, we’ve taken a novel approach to try and overcome the challenges such change has presented.

This approach has taken us close to achieving what few of these firms will – proving that a new drug is safe and effective in its treatment of a disease and getting the product approved by the regulatory authorities. Every day the team and I have learnt something new that has helped us in this quest.

Over the next few months – coming from a different perspective as head of communications – I will try to share some of this knowledge with you via the blog; looking at how and why we do what we do, and trying to address some of the most common questions the company encounters on a day to day basis. I welcome your thoughts and feedback, either through comments on the blog, via Facebook, or directly via email to mail@clinuvel.com

- Lachlan Hay, Head of Global Network and Communications, Clinuvel

If you enjoyed this post, please consider sharing it with others!

Related Posts:

Tags: , , , , , ,

Leave a Reply

 

Clinuvel provides access to Discussions in the good faith that users will abide by the Rules set out below. These rules may change from time to time according to the needs of the Discussions and the Community using them.

To suggest changes or improvements to these rules, please contact a moderator directly.

Any user found in breach of these rules may face disciplinary actions.